Pierre Fabre Laboratories has cut the ribbon on its new U.S. office in Secaucus, NJ, which will host its dermo-cosmetics and medical care subsidiaries.
“This new office is more than just a space, it’s a hub for collaboration, innovation, and showcases the team’s hard work and dedication. It embodies the Group’s commitment to pushing boundaries across both business units in derm-cosmetics and pharmaceutics, while providing New Ways to Care for all,” says Lisa Morris, President and CEO of Pierre Fabre USA, in a news release.
“Today’s office opening demonstrates the steadfast commitment of Pierre Fabre Laboratories to building a powerful presence for medical innovation and patient impact in the U.S.,” adds Adriana Herrera, CEO of Pierre Fabre Pharmaceuticals (PFP).
Eric Ducournau, CEO of Pierre Fabre Laboratories, says, “We have declared the United States a priority geography for the company. The U.S. is not only the biggest market in the world for pharmaceuticals and cosmetics alike, but also the most disruptive market for therapeutic innovation.
“For 15 years, we have built strategic partnerships with highly innovative U.S. biotechnology companies in the fields of oncology, rare diseases, and medical dermatology. We have also multiplied by 10 times the turnover of our blockbuster brand Eau Thermale Avène since 2010, and its potential remains huge given the growing appetite of American consumers for cosmetics designed and tested with the same rigor as for medicines. We are now determined to walk the next step forward, and the opening of our new office in Secaucus with plans to expand in the rare diseases and oncology business is a testimony to this dedication.”
